Mittie Doyle Avalo Therapeutics, Inc. (AVTX) insider trading activity

AVTX Quotes by TradingView

Mittie Doyle is Chief Medical Officer of Avalo Therapeutics, Inc.. Currently has a direct ownership of 3,622 shares of AVTX, which is worth approximately $54,728. The most recent transaction as insider was on Dec 10, 2025, when has been sold 1,013 shares (Common Stock) at a price of $4.1 per share, resulting in proceeds of $4,153. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.62K
n/a 3M change
n/a 12M change
Total Value Held $54,728

Mittie Doyle Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 10 2025
SELL
Payment of exercise price or tax liability
$4,153 $4.1 p/Share
1,013 Reduced 21.86%
3,622 Common Stock

Also insider at

DICE
DICE Therapeutics, Inc. Healthcare
Director
CGEM
Cullinan Oncology, Inc. Healthcare
MD

Mittie Doyle

Chief Medical Officer
South San Francisco, CA

Track Institutional and Insider Activities on AVTX

Follow Avalo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTX shares.

Notify only if

Insider Trading

Get notified when an Avalo Therapeutics, Inc. insider buys or sells AVTX shares.

Notify only if

News

Receive news related to Avalo Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVTX